Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation

New England Journal of Medicine

Volumn 380, Issue 16, 2019, Pages 1509-1524

  Lopes, Renato D ^a   Heizer, Gretchen ^a   Aronson, Ronald ^b   Vora, Amit N ^a   Massaro, Tyler ^a   Mehran, Roxana ^c   Goodman, Shaun G ^d,e   Windecker, Stephan ^f   Darius, Harald ^g   Li, Jia ^b   Averkov, Oleg ⁱ   Bahit, M Cecilia ^j   Berwanger, Otavio ^k   Budaj, Andrzej ^l   Hijazi, Ziad ^m   Parkhomenko, Alexander ⁿ   Sinnaeve, Peter ^o   Storey, Robert F ^p   Thiele, Holger ^h   Vinereanu, Dragos ^q   Granger, Christopher B ^a   Alexander, John H ^a   Hrabar, A D ^r   Caccavo, A ^r   Licheri, A ^r   Alvarisqueta, A F ^r   Abud, A M ^r   Estrada, C ^r   Sueldo, C P ^r   Montenegro, E ^r   Duronto, E A ^r   Blanco, F L ^r   Berra, F C ^r   Ferre Pacora F A ^r   Lopez, G M ^r   Calvo, G ^r   Azize, G M ^r   Luquez, H A ^r   Ramos, H ^r   Colombo, H R ^r   Guetta, J N ^r   Resk, J H ^r   Medrano, J C ^r   Costabel, J P ^r   Carbajales, J ^r   Schiavi, L B ^r   Saggia, L I ^r   Oliva, M A ^r   Casas, M ^r   Snitman, M ^r   Litvak Bruno, M R ^r   Cluigt, N ^r   Vita, N A ^r   Guzman, P N ^r   Zangroniz, P D ^r   Villarreal, R A ^r   Bonato, R R ^r   Nani, S ^r   Sassone, S A ^r   Macin, S M ^r   Arias, V E ^r   Alexopoulos, C ^r   Brieger, D ^r   Colquhoun, D ^r   Heddle, W F ^r   Podczeck Schweighofer, A ^r   Ebner, C ^r   Scherr, D ^r   Lang, I M ^r   Huber, K ^r   Guedes, A ^r   Convens, C ^r   Cools, F ^r   Vercammen, J ^r   Bartunek, J ^r   Rossenbacker, T ^r   Pereira, A H ^r   Kormann, A M ^r   Freitas, A F ^r   Fonseca, A G T ^r   de Quadros, A ^r   Janella, B L ^r   Kalil, C A A ^r   Rodrigues, C S ^r   Precoma, D B ^r   Ramacciotti, E ^r   Resende, E S ^r   Figueiredo, E L ^r   Manenti, E R ^r   Costa, F A D ^r   Feitosa, G ^r   Reis, H J L ^r   Ribeiro, H B ^r   de Moraes, J B M X ^r   Dantas, J M M ^r   Nicolau, J C ^r   Saraiva, J F K ^r   Reolao J ^r   Piegas, L S ^r   Oliveira, L F A ^r   Ritt, L E F ^r   Braile, M C V B ^r   Dracoulakis, M A ^r   de Santos, M O N ^r   Leaes P E ^r   Filho, P P ^r   Rech, R L ^r   Ueda, R ^r   Silvestrini, T L ^r   Michalaros, Y L ^r   Manolova, A ^r   Mihov, A K ^r   Yatseva, B ^r   Velikov, C ^r   Raev, D H ^r   Markov, D ^r   Vassilev, D ^r   Georgiev, E ^r   Benov, H O ^r   Daskalov, I ^r   Petrov, I P ^r   Milanova, M ^r   Shehova Yankova, N S ^r   Lazov, P V ^r   Beleva, S ^r   Marchev, S T ^r   Gelev, V L ^r   Tyrrell, B ^r   Wong, B ^r   Dion, D ^r   LaFlamme, D ^r   Rupka, D W ^r   Shukla, D ^r   Sabbah, E ^r   Nadra, I J ^r   Bata, I ^r   Cherry, J M ^r   Toleva, O ^r   Dehghani, P ^r   Vijayaraghavan, R ^r   Welsh, R ^r   Bagur, R ^r   Labonte, R E ^r   Vizel, S ^r   Fort, S ^r   Huynh, T ^r   Quan, V H ^r   Pesant, Y ^r   Isaza, D ^r   Accini Mendoza, J L ^r   Gomez, J E ^r   Jaramillo Gomez, N I ^r   Knezevic, A ^r   Ruzic, A ^r   Horvat, D ^r   Milicic, D ^r   Selthofer Relatic, K ^r   Pesek, K ^r   Pravecek, M K ^r   Kovacic, M ^r   Manola, S ^r   Persic, V ^r   Alan, D ^r   Belohlavek, J ^r   Larsen, C T ^r   Bronnum Schou J ^r   Veien, K T ^r   Christensen, L S ^r   Maeng, M ^r   Steffensen, R ^r   Angoulvant, D ^r   Beygui, F ^r   Range, G ^r   Cayla, G ^r   Aupetit, J F ^r   Elbaz, M ^r   Delarche, N ^r   Meneveau, N ^r   Ghanem, A ^r   Hagendorff, A ^r   Wilke, A ^r   Hummel, A ^r   Axthelm, C ^r   Kadel, C ^r   Langer, C ^r   Stellbrink, C ^r   Jacobshagen, C ^r   Gross, C M ^r   Blessing, E E B ^r   Minden, H H ^r   Bogossian, H ^r   Wienbergen, H ^r   Ebelt, H ^r   Dreger, H ^r   Ince, H ^r   Akin, I ^r   Eitel, I ^r   Kreis, I ^r   Appel, K F ^r   Maier, L ^r   Bergmann, M ^r   Moser, M ^r   Toursarkissian, N ^r   Menck, N ^r   Ritter, O ^r   Bernhardt, P ^r   Nordbeck, P ^r   Stohring R ^r   Schwinger, R ^r   Braun Dullaeus, R C ^r   Maier, S K G ^r   Schellong, S ^r   Steiner, S ^r   Rudolph, T ^r   Dengler, T J ^r   Geisler, T ^r   Rauch Krohnert U ^r   Jung, W ^r   Jungmair, W ^r   Komocsi A ^r   Papp, A ^r   Vertes A ^r   Mohacsi A ^r   Herczeg, B ^r   Merkely, B ^r   Dezsi C A ^r   Kis, E ^r   Lakatos, F ^r   Kerecsen, G ^r   Piros, G A ^r   Takacs J ^r   Tomcsanyi J ^r   Keltai, K ^r   Kovacs Z ^r   Mathur, A ^r   Baxi, H A ^r   Narendra, J ^r   Gupta, J ^r   Kumbla, M ^r   Jamwal, N K ^r   Arora, P ^r   Katz, A ^r   Shotan, A ^r   Schiff, E ^r   Freedberg, N A ^r   Amir, O ^r   Hussein, O ^r   Kracoff, O H ^r   Alcalai, R ^r   Adawi, S Y ^r   Viskin, S ^r   Hayek, T ^r   Hasin, Y ^r   Rozenman, Y ^r   Nam, C W ^r   Lee, C W ^r   Choi, D J ^r   Jeon, D S ^r   Park, H W ^r   Son, J W ^r   Jeong, J O ^r   Cha, K S ^r   Oh, S ^r   Rha, S W ^r   Park, Y H ^r   On, Y K ^r   Bazzoni Ruiz, A E ^r   Valdespino, A R ^r   Castro Montes, B E ^r   Ramos Lopez, G A ^r   Llamas Esperon G A ^r   Solache, G ^r   Macias Garcia J S ^r   Leiva Pons, J L ^r   De Los Rios Ibarra, M O ^r   Willems, F F ^r   Beyerbacht, H P ^r   van de Wal, R ^r   Hysing, J ^r   Lappegard, K T ^r   Vinge, L E ^r   Halvorsen, S ^r   Ponitz V ^r   Chavez Ayala, C A ^r   Medina Palomino, F A ^r   Garcia Matheus, J C ^r   Wlodarczak A ^r   Lubinski, A ^r   Czarnecka, D ^r   Wojciechowski, D ^r   Skonieczny, G ^r   Kasprzak, J D ^r   Wranicz, J K ^r   Szachniewicz, J ^r   Kincel, K K ^r   Zmudka, K ^r   Lesiak, M ^r   Piekarski, M ^r   Wujkowski, M ^r   Lica Gorzynska, M ^r   Miekus, P ^r   Feusette, P ^r   Bartkowiak, R ^r   Korzeniak, R ^r   Sinkiewicz, W ^r   Musial, W ^r   Krolikowski, Z ^r   Gaspar, A ^r   Pinto, F ^r   Almeida, F ^r   Martinez, J ^r   Brandao L ^r   Santos, L M ^r   Mateus, P ^r   Monteiro, P ^r   Pernencar, S ^r   Mornos C ^r   Olinic, D M ^r   Zdrenghea, D T ^r   Ortan, F O ^r   Cinteza, M ^r   Popescu, M ^r   Voicu, O ^r   Todea, S B F ^r   Babes, V ^r   Vishnevskiy, A Y ^r   Kuimov, A D ^r   Duplyakov, D V ^r   Kosmacheva, E ^r   Pokushalov, E ^r   Gordeev, I G ^r   Zrazhevskiy, K N ^r   Sorokin, L A ^r   Ermoshkina, L G ^r   Zykov, M V ^r   Ruda, M Y ^r   Bulashova, O ^r   Smolenskaya, O G ^r   Orlikova, O V ^r   Grishaev, S L ^r   Shalaev, S V ^r   Boldueva, S A ^r   Kuznetsov, V ^r   Makukhin, V ^r   Kostenko, V ^r   Shvarts, Y ^r   Kobalava, Z D ^r   Selakovic, A ^r   Tosic, B P ^r   Sakac, D B ^r   Pavlovic, M ^r   Dekleva, M ^r   Tasic, N M ^r   Hinic, S ^r   Jozic, T ^r   Potpara, T ^r   Dzupina, A ^r   Pella, D ^r   Majercak, I ^r   Striezova, I ^r   Fedacko, J ^r   Gonsorcik, J ^r   Fecik, J ^r   Selecky, J ^r   Antalik, L ^r   Hranai, M ^r   Gocar, M ^r   Kokles, M ^r   Oriesek, R ^r   Regueiro, A ^r   Ibanez B ^r   Djurovic, D P ^r   Gutierrez Ibanes E ^r   Ridocci Soriano, F ^r   Diaz Fernandez, J ^r   Artaecheverria Zuazo, J J ^r   Escudier Villa, J M ^r   Nunez Villota J ^r   Sanmartin Fernandez, M ^r   Chinchurreta Capote, P A ^r   Munoz Aguilera R ^r   Vera Ripoll, T ^r   Mainar Tello, V ^r   Bjorklund F ^r   Jensen, J ^r   Andersson, J ^r   Lauermann, J ^r   Hamid, M ^r   Angeras O ^r   Fischer, T A ^r   Yagensky, A V ^r   Goloborodko, B I ^r   Kyrychenko, I I ^r   Vakaliuk, I P ^r   Kovalskyy, I ^r   Rishko, M V ^r   Sydor, N ^r   Karpenko, O I ^r   Parkhomenko, O M ^r   Koval, O A ^r   Godlevska, O ^r   Zhurba, S ^r   Maslovskyi, V Y ^r   Netiazhenko, V Z ^r   Tashchuk, V K ^r   Shcherbak, V P ^r   Tseluyko, V I ^r   Cooke, A ^r   Wrigley, B ^r   Francis, C M ^r   Barr, C ^r   Gorog, D A ^r   Lip, G Y H ^r   Irving, J ^r   Mills, J ^r   Levy, T ^r   Cheema, A A ^r   Salacata, A S ^r   Tenaglia, A N ^r   Meholick, A W ^r   Vedere, A R ^r   Patrello, A J ^r   Spaedy, A ^r   Martin, A C ^r   Holland, B H ^r   Duffy, B K ^r   Schuler, B ^r   Treasure, C B ^r   Paraboschi, C ^r   Pickett, C A ^r   Rowan, C J ^r   Longnecker, C R ^r   Hess, C N ^r   Hinchman, D A ^r   Schneider, D J ^r   Murdock, D K ^r   Baldwin, D E ^r   Flores, E A ^r   Sirulnick, E J ^r   Ahmad, F ^r   Aggarwala, G ^r   Dhar, G ^r   Kichura, G M ^r   Turitto, G ^r   Sampognaro, G C ^r   Sharma, G K ^r   Chandna, H ^r   Truong, H T D ^r   Poock, J ^r   Walia, J S ^r   Zelenka, J T ^r   Amin, J K ^r   Foucauld, J ^r   Chambers, J ^r   Abbott, J D ^r   Strobel, J S ^r   Dy, J R ^r   Nour, K A ^r   Sullenberger, L E ^r   Younis, L T ^r   Gonzales, L ^r   Chane, M ^r   Foster, M T ^r   King, M Y ^r   Grabarczyk, M A ^r   Izzo, M R ^r   Leesar, M A ^r   Bernabei, M A ^r   Cavender, M D ^r   Janik, M J ^r   Buchbinder, M ^r   Arcarese, M ^r   Yeh, M ^r   Sheth, M J ^r   Sinno, M C ^r   Shoukfeh, M F ^r   Alhaddad, M ^r   Ranadive, N V ^r   Jaffrani, N A ^r   Little, N K ^r   Shammas, N ^r   Assi, N A ^r   Almousalli, O ^r   Chan, P ^r   Horwitz, P A ^r   Rozeman, P A ^r   Singh, P ^r   Aggarwal, R ^r   Gopinathannair, R ^r   Manshadi, R ^r   Korabathina, R ^r   Gilmore, R M ^r   Feldman, R B ^r   Schnitzler, R N ^r   Harrison, R W ^r   Gandhi, S N ^r   Graham, S ^r   Krueger, S K ^r   Jones, S E ^r   Rowe, S K ^r   Bazaz, S B ^r   Haddad, T M ^r   Povsic, T J ^r   Badami, U A ^r   Abernethy, W B ^r   Mirza, Z A ^r   more..

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f BERN UNIVERSITY HOSPITAL   (Switzerland)

^g Vivantes Neukoelln Medical Center   (Germany)

^h UNIVERSITY OF LEIPZIG   (Germany)

ⁱ PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^j Laboratory of Neuroimaging and Neuroscience (LANEN)   (Argentina)

^k HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^l GROCHOWSKI HOSPITAL   (Poland)

^m UPPSALA UNIVERSITY   (Sweden)

ⁿ Ukranian Strazhesko Institute of Cardiology   (Ukraine)

^o UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^p UNIVERSITY OF SHEFFIELD   (United Kingdom)

^q CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^r NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; PLACEBO; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; PURINERGIC P2Y RECEPTOR ANTAGONIST; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE; VITAMIN K GROUP;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; CAUSE OF DEATH; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOSPITALIZATION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; COMPLICATION; DOUBLE BLIND PROCEDURE; MIDDLE AGED; MULTICENTER STUDY; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FACTOR XA INHIBITORS; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; PYRAZOLES; PYRIDONES; VITAMIN K;

EID: 85063740593     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1817083     Document Type: Article

References (31)

1. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019 January 21 (Epub ahead of print).
2. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64(24): E139-e228.
3. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61(4): E78-e140.
4. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2016; 68: 1082-115.
5. Hansen ML, Sørensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 2010; 170: 1433-41.
6. Lopes RD, Rao M, Simon DN, et al. Triple vs dual antithrombotic therapy in patients with atrial fibrillation and coronary artery disease. Am J Med 2016; 129(6): 592-599.e1.
7. Sørensen R, Hansen ML, Abildstrom SZ, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: A retrospective analysis of nationwide registry data. Lancet 2009; 374: 1967-74.
8. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials. Lancet 2014; 383: 955-62.
9. Cannon CP, Bhatt DL, Oldgren J, et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2017; 377: 1513-24.
10. Gibson CM, Mehran R, Bode C, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 2016; 375: 2423-34.
11. Lopes RD, Vora AN, Liaw D, et al. An open-label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial. Am Heart J 2018; 200: 17-23.
12. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in nonsurgical patients. J Thromb Haemost 2005; 3: 692-4.
13. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
14. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge. Circulation 1987; 76: 142-54.
15. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
16. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation 1998; 98: 1597-603.
17. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998; 339: 1665-71.
18. Rubboli A, Milandri M, Castelvetri C, Cosmi B. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting: Clues for the management of patients with an indication for longterm anticoagulation undergoing coronary stenting. Cardiology 2005; 104: 101-6.
19. Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet 2006; 367: 1903-12.
20. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-67.
21. Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial. Lancet 2007; 370: 493-503.
22. Capodanno D, Mehran R, Valgimigli M, et al. Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nat Rev Cardiol 2018; 15: 480-96.
23. Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet 2013; 381: 1107-15.
24. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-51.
25. Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093-104.
26. Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-92.
27. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-91.
28. Angiolillo DJ, Goodman SG, Bhatt DL, et al. Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention. Circulation 2018; 138: 527-36.
29. Lip GYH, Collet JP, Haude M, Huber K. Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A summary of the joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Eur Heart J 2018; 39: 2847-50.
30. Pérez-Gómez F, Alegría E, Berjón J, et al. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: A randomized multicenter study. J Am Coll Cardiol 2004; 44: 1557-66.
31. Wang TY, Robinson LA, Ou FS, et al. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: Physician practice in the CRUSADE registry. Am Heart J 2008; 155: 361-8.